Oncotelic Therapeutics, Inc. Proceeds from Sale and Maturity of Marketable Securities
Oncotelic Therapeutics, Inc. (OTLC) reported Proceeds from Sale and Maturity of Marketable Securities of $2.29 million for the 12-month period ending 2009-12-31, per its 10-K filed 2012-03-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2012-03-28
- Oncotelic Therapeutics, Inc. proceeds from sale and maturity of marketable securities for fiscal 2009 was $2.29M.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|
| 2009-12-31 | $2.29M 10-K · filed 2012-03-28 |